Stallion India Fluorochemicals Approves Allotment of 3.67 Crore Shares via Rights Issue
Stallion India Fluorochemicals Limited's Rights Issue Committee approved the allotment of 3,67,60,483 equity shares at ₹99.00 per share. The issue was on a 19:41 rights basis, with a record date of 11th February, 2026. This allotment follows the Letter of Offer dated 12th February, 2026.
The rights issue involves the allotment of a significant number of shares, which will impact the company's capital structure and potentially dilute existing shareholders' stakes. The successful fundraising is generally positive but the extent of the impact depends on how the funds are utilized.
The company successfully completed a rights issue, which typically strengthens its equity base and provides capital for growth or other strategic initiatives. The approval of allotment signifies a positive step in the fundraising process.
Stallion India Fluorochemicals Limited announced the outcome of its Rights Issue Committee meeting held on Monday, 2nd March, 2026. The committee approved the allotment of 3,67,60,483 fully paid-up equity shares. These shares, with a face value of ₹10.00 each, were issued on a rights basis in the ratio of 19:41, meaning 19 rights equity shares for every 41 equity shares held by eligible shareholders. The issue price was ₹99.00 per equity share, based on the record date of 11th February, 2026.
The allotment is in accordance with the Letter of Offer dated 12th February, 2026, and the Basis of Allotment approved by BSE Limited, the designated stock exchange. Following this allotment, the company's paid-up equity share capital has increased. The announcement also confirmed the extinguishment of lapsed rights entitlements and deactivation of the corresponding ISIN.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under rights issue. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.